Research Study

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Phase 2a Study to Explore the Efficacy and Safety of Tezepelumab in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) (COURSE)
Principal Investigator 
Mark FitzGerald

Overview

Body Locations and Systems 
COPD
ClinicalTrials.gov# 
NCT04039113
Status 
Recruiting
Study Start/End 
Oct 28, 2019 to Dec 31, 2020
Locations 
Diamond Health Care Centre
Name/Title 
Linda Hui, Research Nurse
Phone 
604-875-5698
Email Address 
linda.hui@ubc.ca
Purpose of Study 

The purpose of this study is to explore the efficacy and safety of tezepelumab in adults with moderate to very severe chronic obstructive pulmonary disease (COPD).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.